Data presented at ASCO 2020 of a pooled biomarker analysis of the MONALEESA phase III trials evaluating ribociclib sensitivity in breast cancer
Thomas Bachelot, MD, PhD, provides insights on managing HER2-positive metastatic breast cancer with new therapies in this slideset from Clinical Care Options.
In this slideset from Clinical Care Options, Adam Brufsky, MD, PhD; Cristina Saura, MD, PhD, and Thomas Bachelot, MD, PhD, provides insights on management of HER2-positive metastatic breast cancer
In this slideset from Clinical Care Options, Cristina Saura, MD, PhD, provides insights on using newer TKIs for HER2-positive metastatic breast cancer.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.